IRONWOOD PHARMACEUTICALS, INC. Current Liabilities
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Current Liabilities of $32.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $32.85M.
- 2026-03-31: Liabilities, Current $236.31M.
- 2025-12-31: Liabilities, Current $242.22M.
- 2025-09-30: Liabilities, Current $242.50M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $32.85M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $236.31M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $242.22M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $242.50M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $232.53M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $48.10M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $38.85M 10-K · filed 2026-02-26 |
| 2024-09-30 | $49.38M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $45.51M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $252.44M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $276.10M 10-K · filed 2025-03-31 |
| 2023-09-30 | $280.58M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $305.39M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $23.84M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $25.52M 10-K · filed 2024-02-16 |
| 2022-09-30 | $27.12M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $23.30M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $147.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $161.70M 10-K · filed 2023-02-16 |
| 2021-09-30 | $145.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $134.37M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $23.60M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $32.17M 10-K · filed 2022-02-18 |
| 2020-09-30 | $32.90M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $26.70M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $27.59M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $40.93M 10-K · filed 2021-02-17 |
| 2019-09-30 | $52.80M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $110.86M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $118.57M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $119.52M 10-K · filed 2020-02-13 |
| 2018-09-30 | $112.58M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $94.98M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $62.34M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $66.03M 10-K · filed 2019-02-25 |
| 2017-09-30 | $64.49M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $79.97M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $78.89M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $91.13M 10-K · filed 2018-02-22 |
| 2016-09-30 | $95.31M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $91.00M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $78.11M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $76.47M 10-K · filed 2017-02-22 |
| 2015-09-30 | $67.78M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $62.10M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $59.81M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $60.54M 10-K · filed 2016-02-19 |
| 2014-09-30 | $54.06M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $41.63M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $38.50M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $41.04M 10-K · filed 2015-02-18 |
| 2013-09-30 | $39.70M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $43.97M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $62.68M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $54.94M 10-K · filed 2014-02-07 |
| 2012-09-30 | $35.58M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $49.12M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $52.28M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $65.13M 10-K · filed 2013-02-21 |
| 2011-09-30 | $70.85M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $70.84M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $64.43M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |